Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology · Primary Ovarian Insufficiency

Causes, Genetics, and Associated Conditions

At a Glance

While 60 to 90 percent of primary ovarian insufficiency (POI) cases have no known cause, identifying a genetic or autoimmune root is critical. Testing for genetic conditions like the FMR1 premutation and autoimmune adrenal insufficiency protects your long-term health and your family's.

Understanding why Primary Ovarian Insufficiency (POI) occurs is a critical part of your care. While it is frustrating to hear that 60% to 90% of cases are classified as idiopathic (meaning the cause cannot currently be identified), uncovering a cause when possible can provide a roadmap for your future health and the health of your family [1][2].

Genetic Factors and Family Health

Genetic causes are found in roughly 10% to 15% of women with POI [3]. Because these causes are “written” in your DNA, they can have implications for your relatives.

  • Turner Syndrome: This is one of the most common genetic causes, occurring when one of the two X chromosomes is missing or altered [3].
  • FMR1 Premutation: About 3.8% of women with POI carry a “premutation” in the FMR1 gene [4]. Identifying this is vital because it can be passed to children, where it may lead to Fragile X Syndrome, a condition causing intellectual disability [5]. It also alerts you and your family to the risk of FXTAS (Fragile X-associated tremor/ataxia syndrome), a neurological condition that can affect carriers later in life [6].
  • Other Genes: Researchers have identified several other genes (such as NOBOX or GDF9) that can run in families and contribute to the loss of ovarian function [7][8].

Autoimmune Connections

The immune system is designed to protect you, but in some cases, it mistakenly attacks the ovaries. Autoimmune causes account for 4% to 30% of POI cases [9][10].

  • Thyroid Disease: Hashimoto’s thyroiditis is the most common autoimmune condition found alongside POI [9][11]. Your doctor will likely test for TPO antibodies to see if your thyroid is affected.
  • Adrenal Risk: Testing for the 21-hydroxylase antibody is perhaps the most important safety test after a POI diagnosis [9]. If this antibody is present, you have a significantly higher risk of developing Addison’s disease, a life-threatening condition where the adrenal glands fail to produce essential hormones. Knowing this risk allows doctors to monitor you closely and prevent an adrenal crisis. Key warning signs of adrenal insufficiency include extreme fatigue, unexplained weight loss, dizziness when standing, and intense salt cravings [12].

Iatrogenic (Medical) Causes

Sometimes, the loss of ovarian function is a side effect of medical treatments required for other health conditions. This is called iatrogenic POI.

  • Chemotherapy: Certain drugs, especially alkylating agents (like cyclophosphamide), are “gonadotoxic,” meaning they can damage or destroy the eggs within the ovaries [13][14].
  • Radiation: Radiation therapy to the pelvic area can directly damage ovarian tissue [15].
  • Surgery: The surgical removal of both ovaries (bilateral oophorectomy) causes immediate POI. Other surgeries, such as those for severe endometriosis or large cysts, can sometimes reduce the blood supply to the ovaries or decrease the number of remaining eggs [16][17].

Why Finding the Cause Matters

Pinpointing the cause of POI is not just about having an answer; it is about proactive management. Identifying a genetic cause helps your sisters or daughters understand their own risks. Identifying an autoimmune cause can save your life by spotting adrenal failure before it becomes an emergency. If your POI is idiopathic, it means that while we don’t have an answer today, your care will focus on managing symptoms and protecting your bone and heart health [18].

Common questions in this guide

Why did I develop primary ovarian insufficiency?
In 60 to 90 percent of cases, the cause of POI is idiopathic, meaning an exact reason cannot be found. Other cases are caused by genetic factors, autoimmune conditions, or previous medical treatments like chemotherapy or surgery.
What genetic tests are recommended for premature menopause?
Doctors often recommend testing for Turner Syndrome and the FMR1 gene premutation. Finding a genetic cause is important because it can affect your family members and help guide your overall healthcare.
Why do I need to be tested for the 21-hydroxylase antibody if I have POI?
This antibody test checks for your risk of developing Addison's disease, a serious autoimmune condition that affects the adrenal glands. Knowing this risk allows your doctor to monitor you and prevent a life-threatening adrenal crisis.
Can autoimmune diseases cause premature menopause?
Yes, autoimmune conditions account for up to 30 percent of POI cases. The immune system mistakenly attacks the ovaries, and this is frequently linked with other autoimmune issues like Hashimoto's thyroiditis.
Will past cancer treatments lead to POI?
Medical treatments like pelvic radiation, bilateral oophorectomy, and certain chemotherapy drugs can damage ovarian tissue and deplete your egg supply. This is known as iatrogenic POI and requires specific long-term health monitoring.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my POI diagnosis, have I been screened for the 21-hydroxylase antibody to check for adrenal risk?
  2. 2.Is my POI considered idiopathic, or have we completed all the recommended first-tier genetic and autoimmune tests?
  3. 3.Should I be referred to a genetic counselor to discuss the implications of FMR1 testing for my family?
  4. 4.Are there specific autoimmune conditions, like Hashimoto's, that I should be screened for regularly?
  5. 5.If my POI was caused by previous medical treatments (like chemotherapy), does that change my long-term health monitoring?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Position statement on the diagnosis and management of premature/primary ovarian insufficiency (except Turner Syndrome).

    Christin-Maitre S, Givony M, Albarel F, et al.

    Annales d'endocrinologie 2021; (82(6)):555-571 doi:10.1016/j.ando.2021.09.001.

    PMID: 34508691
  2. 2

    Premature ovarian insufficiency - the need for a genomic map.

    Cloke B, Rymer J

    Climacteric : the journal of the International Menopause Society 2021; (24(5)):444-452 doi:10.1080/13697137.2021.1945025.

    PMID: 34308731
  3. 3

    Evaluation and Management of Primary Ovarian Insufficiency in Adolescents and Young Adults.

    Kanj RV, Ofei-Tenkorang NA, Altaye M, Gordon CM

    Journal of pediatric and adolescent gynecology 2018; (31(1)):13-18 doi:10.1016/j.jpag.2017.07.005.

    PMID: 28782660
  4. 4

    Association between mutations in the FMR1 gene and ovarian dysfunction in Brazilian patients.

    Ramos C, Ocampos M, Barbato IT, et al.

    JBRA assisted reproduction 2022; (26(2)):237-240 doi:10.5935/1518-0557.20210063.

    PMID: 34542254
  5. 5

    Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review.

    Fink DA, Nelson LM, Pyeritz R, et al.

    Frontiers in genetics 2018; (9()):529 doi:10.3389/fgene.2018.00529.

    PMID: 30542367
  6. 6

    Population-based FMR1 carrier screening among reproductive women.

    Ain Q, Hwang YH, Yeung D, et al.

    Journal of assisted reproduction and genetics 2024; (41(11)):3237-3243 doi:10.1007/s10815-024-03242-2.

    PMID: 39320553
  7. 7

    A homozygous truncating variant in GDF9 in siblings with primary ovarian insufficiency.

    Verma KP, Thompson B, Wolfe J, et al.

    Journal of assisted reproduction and genetics 2021; (38(6)):1539-1543 doi:10.1007/s10815-021-02144-x.

    PMID: 33797006
  8. 8

    Primary ovarian insufficiency due to homozygous variants in the homeobox transcription factor NOBOX.

    Zidoune H, Mezhoud I, Elzaiat M, et al.

    Molecular biology reports 2025; (53(1)):150 doi:10.1007/s11033-025-11252-1.

    PMID: 41324758
  9. 9

    Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.

    Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al.

    International journal of molecular sciences 2021; (22(5)) doi:10.3390/ijms22052594.

    PMID: 33807517
  10. 10

    Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal.

    Kirshenbaum M, Orvieto R

    Journal of assisted reproduction and genetics 2019; (36(11)):2207-2215 doi:10.1007/s10815-019-01572-0.

    PMID: 31440958
  11. 11

    Premature ovarian failure.

    Jankowska K

    Przeglad menopauzalny = Menopause review 2017; (16(2)):51-56 doi:10.5114/pm.2017.68592.

    PMID: 28721130
  12. 12

    Premature ovarian insufficiency and autoimmune diseases.

    Domniz N, Meirow D

    Best practice & research. Clinical obstetrics & gynaecology 2019; (60()):42-55 doi:10.1016/j.bpobgyn.2019.07.008.

    PMID: 31495598
  13. 13

    Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.

    Tuin J, Sanders JS, van Beek AP, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(4)):986-92 doi:10.1002/art.39522.

    PMID: 27023359
  14. 14

    Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery Time.

    Lee EH, Han SE, Park MJ, et al.

    Journal of menopausal medicine 2018; (24(3)):196-203 doi:10.6118/jmm.2018.24.3.196.

    PMID: 30671413
  15. 15

    Can vildagliptin protect against radiation-induced premature ovarian failure? Insights into the AMPK and AKT signaling pathways.

    Mahgoub NA, El-Sherbiny DA, El-Demerdash E

    BMC pharmacology & toxicology 2025; (26(1)):81 doi:10.1186/s40360-025-00903-5.

    PMID: 40221811
  16. 16

    Rates of premature ovarian insufficiency and surgical menopause in patients with endometriosis.

    Simko S, Gwizdala J, Cooley N, et al.

    Journal of gynecology obstetrics and human reproduction 2026; (55(7)):103215 doi:10.1016/j.jogoh.2026.103215.

    PMID: 42155811
  17. 17

    Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma.

    Salama M, Isachenko E, Rahimi G, et al.

    Oncology (Williston Park, N.Y.) 2021; (35(6)):332-334 doi:10.46883/ONC.2021.3506.0332.

    PMID: 34147055
  18. 18

    Evidence-based guideline: premature ovarian insufficiency†‡.

    , Panay N, Anderson RA, et al.

    Climacteric : the journal of the International Menopause Society 2024; (27(6)):510-520 doi:10.1080/13697137.2024.2423213.

    PMID: 39647506

This page provides educational information about the causes of primary ovarian insufficiency (POI). Always consult your gynecologist or endocrinologist for medical advice and specialized genetic or autoimmune testing.

Get notified when new evidence is published on premature menopause.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.